关注
Andre Daher
Andre Daher
Oswaldo Cruz Foundation Fiocruz Clinical Research Platform Coordinator
在 fiocruz.br 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta …
RJ Commons, JA Simpson, K Thriemer, GS Humphreys, T Abreha, ...
The Lancet Infectious Diseases 18 (9), 1025-1034, 2018
1152018
Evaluation of Plasmodium vivax malaria recurrence in Brazil
A Daher, JCAL Silva, A Stevens, P Marchesini, CJ Fontes, FO Ter Kuile, ...
Malaria journal 18, 1-10, 2019
412019
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance …
RJ Commons, JA Simpson, K Thriemer, CS Chu, NM Douglas, T Abreha, ...
BMC medicine 17, 1-13, 2019
402019
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and …
RJ Commons, JA Simpson, K Thriemer, T Abreha, I Adam, NM Anstey, ...
PLoS medicine 16 (10), e1002928, 2019
352019
Global access to quality-assured medical products: the Oxford statement and call to action
PN Newton, KC Bond, P Newton, K Bond, V Abiola, K Ade-Abolade, ...
The Lancet Global Health 7 (12), e1609-e1611, 2019
342019
Effect of artesunate-mefloquine fixed-dose combination in malaria transmission in amazon basin communities
AC Santelli, I Ribeiro, A Daher, M Boulos, PB Marchesini, ...
Malaria journal 11, 1-12, 2012
342012
Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria
NN Chamma-Siqueira, SC Negreiros, SB Ballard, S Farias, SP Silva, ...
New England Journal of Medicine 386 (13), 1244-1253, 2022
292022
Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax
R Milligan, A Daher, G Villanueva, H Bergman, PM Graves
Cochrane Database of Systematic Reviews, 2020
262020
Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria
R Milligan, A Daher, PM Graves
Cochrane Database of Systematic Reviews, 2019
252019
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
A Daher, G Aljayyoussi, D Pereira, MVG Lacerda, MAA Alexandre, ...
Malaria Journal 18, 1-9, 2019
222019
Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open …
A Daher, D Pereira, MVG Lacerda, MAA Alexandre, CT Nascimento, ...
Malaria Journal 17, 1-11, 2018
202018
Safety, efficacy and pharmacokinetic evaluations of a new coated chloroquine tablet in a single-arm open-label non-comparative trial in Brazil: a step towards a user-friendly …
D Pereira, A Daher, G Zanini, I Maia, L Fonseca, L Pitta, R Ruffato, ...
Malaria Journal 15, 1-10, 2016
192016
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
RJ Commons, M Rajasekhar, P Edler, T Abreha, GR Awab, JK Baird, ...
The Lancet Infectious Diseases, 2023
132023
Poor response to azithromycin in cutaneous leishmaniasis leading to a premature interruption of a multicentric phase III clinical trial in Brazil
A Toledo Junior, AB Daher, TA Amaral, SFG Carvalho, GAS Romero, ...
Revista da Sociedade Brasileira de Medicina Tropical 47, 756-762, 2014
122014
Using a single tablet daily to treat latent tuberculosis infection in Brazil: bioequivalence of two different isoniazid formulations (300 mg and 100 mg) demonstrated by a …
A Daher, L Pitta, T Santos, D Barreira, D Pinto
Memórias do Instituto Oswaldo Cruz 110, 543-550, 2015
92015
Variability in white blood cell count during uncomplicated malaria and implications for parasite density estimation: a WorldWide Antimalarial Resistance Network individual …
Malaria Journal 22 (1), 174, 2023
32023
Efficacy and safety of granulocyte-colony stimulating factor therapy in Chagas cardiomyopathy: a phase II double-blind, randomized, placebo-controlled clinical trial
CT Macedo, TF Larocca, M Noya-Rabelo, R Aras Jr, CRB Macedo, ...
Frontiers in Cardiovascular Medicine 9, 864837, 2022
32022
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual …
P Mehdipour, M Rajasekhar, S Dini, S Zaloumis, T Abreha, I Adam, ...
Malaria Journal 22 (1), 306, 2023
22023
Pharmacokinetics of chloroquine and primaquine in healthy volunteers
A Daher, DP Pinto, LB da Fonseca, HM Pereira, DMD da Silva, ...
Malaria journal 21, 1-7, 2022
12022
Guia de Medicamentos 2006
AL Fonseca, AMS Pereira, AB Daher, CAP Gomes, LAM Pereira, ...
Guia de Medicamentos 2006, 912-912, 2006
12006
系统目前无法执行此操作,请稍后再试。
文章 1–20